1. Inadequate conflict of interest policies at most French teaching hospitals: A survey and website analysis
- Author
-
Barbara Mintzes, Paul Scheffer, Véronique Gaillac, Christian Guy-Coichard, Anne Chailleu, and Gabriel Perraud
- Subjects
Economics ,Social Sciences ,01 natural sciences ,Geographical locations ,0302 clinical medicine ,Sociology ,Surveys and Questionnaires ,Health care ,Medicine and Health Sciences ,030212 general & internal medicine ,Multidisciplinary ,Commerce ,Organizational Policy ,Europe ,Medicine ,Engineering and Technology ,France ,Research Article ,Biotechnology ,Procurement ,Science ,Political Science ,education ,Public policy ,Context (language use) ,Bioengineering ,Public Policy ,Disclosure ,Education ,03 medical and health sciences ,Politics ,Health Economics ,Political science ,Humans ,European Union ,0101 mathematics ,Hospitals, Teaching ,Curriculum ,Medical education ,Internet ,Health economics ,Health Care Policy ,business.industry ,Conflict of Interest ,010102 general mathematics ,Conflict of interest ,Biology and Life Sciences ,Health Care ,Medical Education ,Medical Devices and Equipment ,People and places ,business ,Medical Humanities - Abstract
Background. There are 32 teaching hospitals in France, including 30 University hospitals and 2 Regional teaching hospitals. Teaching hospitals have three roles: health care provision, training of healthcare professionals, and medical research. These roles lead to frequent interactions with pharmaceutical and medical device companies, inevitably raising major risks of conflicts of interests. Therefore, policies to manage conflict of interests (COI) are crucial. This study aims to examine COI policies in French teaching hospitals. . Methods. All French teaching hospitals (n=32) were included in this study. All hospitals websites were screened for institutional COI policies and curriculum on COI, using standardized keyword searches. More data were collected through a questionnaire addressed to each chief executive officer (CEO) of the teaching hospital. We used predefined criteria (n= 20) inspired by similar surveys on COI policies in French, US and Canadian medical schools, with some additions to reflect the local hospital context. A global score for each hospital, ranging from 0 to 58 (higher scores denoting stronger policies) was calculated by summing points obtained for each criterion. Results. Three out of 32 (9%) CEOs replied to the questionnaire. All 32 hospitals had websites; 16 hospitals listed policies or regulations on their websites or provided them on request. In December 2017, among the 32 hospitals, we found that 17 (53.1%) had rules and regulations for some items only, 4 (12.5%) have considered implementing a policy, two of which (6.3%) have begun implementation. and 15 (46.9%) had no evidence of COI policies and a null score. The maximum global score was 24 out of 58, with a mean of 3.50 ± 5.72. Conclusion. This is the first systematic assessment of COI policies in teaching hospitals in France. Such policies are needed to protect patients, clinicians and students from undue commercial influence. Despite public and political pressure for better management of COI since France’s benfluorex (Mediator) scandal of 2010, few teaching hospitals have implemented comprehensive and protective policies. We hope that periodic ranking of hospitals will contribute to raise awareness of the importance of COI policy and speed introduction.
- Published
- 2019